Warberg Asset Management »

Carmell Therapeutics Corp - US shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 45k 0.40
2024-06-30 $60k 45k 1.33

More positions owned by Warberg Asset Management

Invesco Qqq Tr Put Put Option
Spdr S&p 500 Etf Tr Put Put Option
Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Parsons Corp Del Note 0.250% 8/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
United States Stl Corp Note 5.000%11/0 (Principal)
Box Note 1/1 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Axon Enterprise Note 0.500%12/1 (Principal)
Microsoft Corp Put Put Option
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Bloomin Brands Note 5.000% 5/0 (Principal)
Nrg Energy DBCV 2.750% 6/0 (Principal)

View all positions for Warberg Asset Management

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US